Fidelity International’s Burning Rock Biotech BNR Stock Holding History

Fidelity International’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-280,898	Closed	-$1.18M	–	976
2025 Q1	$1.18M	Hold	280,898	–	–	﹤0.01%	713
2024 Q4	$1.9M	Hold	280,898	–	–	﹤0.01%	687
2024 Q3	$919K	Hold	280,898	–	–	﹤0.01%	733
2024 Q2	$1.77M	Hold	280,898	–	–	﹤0.01%	692
2024 Q1	$2.05M	Hold	280,898	–	–	﹤0.01%	680
2023 Q4	$2.61M	Hold	280,898	–	–	﹤0.01%	651
2023 Q3	$2.72M	Hold	280,898	–	–	﹤0.01%	609
2023 Q2	$6.12M	Hold	280,898	–	–	0.01%	542
2023 Q1	$7.89M	Hold	280,898	–	–	0.01%	515
2022 Q4	$6.32M	Buy	+280,898	New	+$6.41M	0.01%	548

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

CRCM LP San Francisco, California $152M AUM 26.3% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity International's BNR Position: Q2 2025 in Review

Fidelity International sold out of Burning Rock Biotech (BNR) in Q2 2025, closing a stake of 280,898 shares — an estimated $1.18M sold.

Fidelity International first reported a position in BNR in Q4 2022 and held it in 10 quarters. The position peaked at $7.89M in Q1 2023. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2025.

Fidelity International reported no remaining Burning Rock Biotech position as of Q2 2025 after selling out during the quarter.
Fidelity International sold 280,898 Burning Rock Biotech shares in Q2 2025, an estimated $1.18M.
Fidelity International first reported a position in Burning Rock Biotech in Q4 2022 and held it in 10 quarters.
Fidelity International's Burning Rock Biotech position peaked at $7.89M in Q1 2023.
17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2025.

Based on Fidelity International's 13F filing for Q2 2025, filed 14 Aug 2025.